Skip to contentA
Astrana Health, Inc.
A
ASTHAstrana Health, Inc. Q1 2024 · 10-Q
Revenue$404.36M$404.36M+19.9% vs Q1 2023 Net Income$14.84M$14.84M+13.0% vs Q1 2023 EPS Diluted$0.31$0.31+10.7% vs Q1 2023 Operating Income$30,139,000+34.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Astrana Health, Inc. · CIK 1083446 · Engraved from SEC EDGAR
Free Cash Flowderived$5,608,000+231.2% Margins · derivedOperating margin7.5%+0.8 pt vs Q1 2023
Net margin3.7%−0.2 pt vs Q1 2023
ended Mar 31, 2024 · filed May 9, 2024 · 39 d after period end